Grant: Discovery Grants Program - Individual
Université de Montréal
$58,000.00
The structure-function relationships between capsular polysaccharides and the immune system during Streptococcus suis infections
EF 2022-23
Résumé
The compulsory reduction in livestock antibiotic use and lack of vaccines have led to the re-emergence of bacterial pathogens responsible for significant economic loss and a surge in animal welfare concerns, particularly in the swine industry. Among these pathogens, encapsulated bacteria are challenging due to the camouflage conferred by their capsular polysaccharide (CPS), which cloaks antigenic proteins on the bacterial surface that would otherwise trigger a protective immune response. The encapsulated bacterium Streptococcus suis (S. suis) has been classified as one of the swine industry's high-priority bacterial species based on the need for intervention tools. Due to the CPS, S. suis is generally highly resistant to phagocytic clearance, except in the presence of opsonizing antibodies, which facilitate bacterial elimination. Even so, the development of adaptive (humoral) immunity during S. suis infection is still poorly understood and thus translates into a lack of commercial vaccines to fight this disease in pigs. During the adaptive immune response, B cells are activated through antigen engagement, and T cell help. Together with somatic hypermutation and class-switch recombination, B cell clonal expansion in germinal centers mediate final antibody response fitness. Besides this classical T cell-dependent mechanism, antibody responses can emerge from T cell-independent pathways, especially those directed against the CPS. In the context of S. suis, these aspects are largely unknown. Furthermore, based on current knowledge on S. suis CPS serotypes and their behaviours, divergent B cell responses are expected. The general hypothesis is that encapsulated S. suis infections modulate the development of the adaptive immune response to the pathogen. Moreover, the role of S. suis CPSs differs between serotypes, and this feature impacts the dynamics and functionality of the antibody response. Building on our expertise, the general aim is to dissect the molecular and cellular pathways involved in the humoral adaptive immune response to encapsulated S. suis. Different methods will be used to understand how encapsulated S. suis modulates B cell activation and, consequently, antibody diversification. Molecular studies of the dynamic landscape in blood/tissues of infected/immunized animals will be combined with FACS analyses to provide a mechanistic understanding of B cell activation. Selected conditions will be used to evaluate the influence of the CPS type on the humoral response. We will characterize the antibody response and biological properties of induced antibodies. This program will generate fundamental knowledge on the immune response to encapsulated organisms and their carbohydrates, as well as provide a mechanistic understanding to design future vaccine strategies against S. suis - a development that is of utmost significance for swine production systems aiming to reduce antimicrobial use.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2021-03020
Name nom
Segura, Mariela
Department département
Médecine, Faculté de - Médecine, Faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2021
Award amount
58000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Installment
inst:2
Partie
1
Nb partie
5
Application title
The structure-function relationships between capsular polysaccharides and the immune system during Streptococcus suis infections
Application summary
The compulsory reduction in livestock antibiotic use and lack of vaccines have led to the re-emergence of bacterial pathogens responsible for significant economic loss and a surge in animal welfare concerns, particularly in the swine industry. Among these pathogens, encapsulated bacteria are challenging due to the camouflage conferred by their capsular polysaccharide (CPS), which cloaks antigenic proteins on the bacterial surface that would otherwise trigger a protective immune response. The encapsulated bacterium Streptococcus suis (S. suis) has been classified as one of the swine industry's high-priority bacterial species based on the need for intervention tools. Due to the CPS, S. suis is generally highly resistant to phagocytic clearance, except in the presence of opsonizing antibodies, which facilitate bacterial elimination. Even so, the development of adaptive (humoral) immunity during S. suis infection is still poorly understood and thus translates into a lack of commercial vaccines to fight this disease in pigs. During the adaptive immune response, B cells are activated through antigen engagement, and T cell help. Together with somatic hypermutation and class-switch recombination, B cell clonal expansion in germinal centers mediate final antibody response fitness. Besides this classical T cell-dependent mechanism, antibody responses can emerge from T cell-independent pathways, especially those directed against the CPS. In the context of S. suis, these aspects are largely unknown. Furthermore, based on current knowledge on S. suis CPS serotypes and their behaviours, divergent B cell responses are expected. The general hypothesis is that encapsulated S. suis infections modulate the development of the adaptive immune response to the pathogen. Moreover, the role of S. suis CPSs differs between serotypes, and this feature impacts the dynamics and functionality of the antibody response. Building on our expertise, the general aim is to dissect the molecular and cellular pathways involved in the humoral adaptive immune response to encapsulated S. suis. Different methods will be used to understand how encapsulated S. suis modulates B cell activation and, consequently, antibody diversification. Molecular studies of the dynamic landscape in blood/tissues of infected/immunized animals will be combined with FACS analyses to provide a mechanistic understanding of B cell activation. Selected conditions will be used to evaluate the influence of the CPS type on the humoral response. We will characterize the antibody response and biological properties of induced antibodies. This program will generate fundamental knowledge on the immune response to encapsulated organisms and their carbohydrates, as well as provide a mechanistic understanding to design future vaccine strategies against S. suis - a development that is of utmost significance for swine production systems aiming to reduce antimicrobial use.